Trial intelligence / Profile preview

Propofol vs esketamine sedation for cardiac vascular surgery

ChiCTR2500097877Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine and propofol in arrhythmogenic cardiomyopathy (ACM) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Mechanical ventilation time. Planned start Feb 2025; status: not yet recruiting.

02

Drugs

esketaminepropofol
03

Conditions

arrhythmogenic cardiomyopathy (ACM)

Beyond the preview

Go deeper on ChiCTR2500097877.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500097877.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call